170 related articles for article (PubMed ID: 18608095)
41. [Clinical characteristics of amyotrophic lateral sclerosis subsets].
Pradat PF; Bruneteau G
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S29-4S33. PubMed ID: 17128087
[TBL] [Abstract][Full Text] [Related]
42. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
Murphy M; Quinn S; Young J; Parkin P; Taylor B
Neurology; 2008 Dec; 71(23):1889-95. PubMed ID: 19047561
[TBL] [Abstract][Full Text] [Related]
43. Clinical and prognostic features of ALS/MND in different phenotypes-data from a hospital-based registry.
Wei QQ; Chen Y; Chen X; Cao B; Ou R; Zhang L; Hou Y; Shang H
Brain Res Bull; 2018 Sep; 142():403-408. PubMed ID: 30232045
[TBL] [Abstract][Full Text] [Related]
44. Duration of amyotrophic lateral sclerosis is age dependent.
Eisen A; Schulzer M; MacNeil M; Pant B; Mak E
Muscle Nerve; 1993 Jan; 16(1):27-32. PubMed ID: 8423829
[TBL] [Abstract][Full Text] [Related]
45. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis.
Desport JC; Marin B; Funalot B; Preux PM; Couratier P
Amyotroph Lateral Scler; 2008 Oct; 9(5):273-8. PubMed ID: 18720089
[TBL] [Abstract][Full Text] [Related]
46. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
[TBL] [Abstract][Full Text] [Related]
47. Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China.
Chen L; Zhang B; Chen R; Tang L; Liu R; Yang Y; Yang Y; Liu X; Ye S; Zhan S; Fan D
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1075-81. PubMed ID: 26124198
[TBL] [Abstract][Full Text] [Related]
48. The pseudopolyneuritic form of amyotrophic lateral sclerosis (Patrikios' disease).
Cappellari A; Ciammola A; Silani V
Electromyogr Clin Neurophysiol; 2008 Mar; 48(2):75-81. PubMed ID: 18435211
[TBL] [Abstract][Full Text] [Related]
49. From clues to mechanisms: understanding ALS initiation and spread.
Armon C
Neurology; 2008 Sep; 71(12):872-3. PubMed ID: 18794489
[No Abstract] [Full Text] [Related]
50. [Phenotypic variation in ALS].
Sasaki S
Rinsho Shinkeigaku; 2006 Nov; 46(11):825-7. PubMed ID: 17432191
[TBL] [Abstract][Full Text] [Related]
51. Natural history and clinical features of the flail arm and flail leg ALS variants.
Wijesekera LC; Mathers S; Talman P; Galtrey C; Parkinson MH; Ganesalingam J; Willey E; Ampong MA; Ellis CM; Shaw CE; Al-Chalabi A; Leigh PN
Neurology; 2009 Mar; 72(12):1087-94. PubMed ID: 19307543
[TBL] [Abstract][Full Text] [Related]
52. Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis.
Fujimura-Kiyono C; Kimura F; Ishida S; Nakajima H; Hosokawa T; Sugino M; Hanafusa T
J Neurol Neurosurg Psychiatry; 2011 Nov; 82(11):1244-9. PubMed ID: 21921087
[TBL] [Abstract][Full Text] [Related]
53. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort.
Berlowitz DJ; Howard ME; Fiore JF; Vander Hoorn S; O'Donoghue FJ; Westlake J; Smith A; Beer F; Mathers S; Talman P
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):280-6. PubMed ID: 25857659
[TBL] [Abstract][Full Text] [Related]
54. Primary lateral sclerosis.
Singer MA; Statland JM; Wolfe GI; Barohn RJ
Muscle Nerve; 2007 Mar; 35(3):291-302. PubMed ID: 17212349
[TBL] [Abstract][Full Text] [Related]
55. Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).
Jawdat O; Statland JM; Barohn RJ; Katz JS; Dimachkie MM
Neurol Clin; 2015 Nov; 33(4):775-85. PubMed ID: 26515621
[TBL] [Abstract][Full Text] [Related]
56. Neurophysiological index as a biomarker for ALS progression: validity of mixed effects models.
Cheah BC; Vucic S; Krishnan AV; Boland RA; Kiernan MC
Amyotroph Lateral Scler; 2011 Jan; 12(1):33-8. PubMed ID: 21271790
[TBL] [Abstract][Full Text] [Related]
57. [Pronostic factors and survival in motor neuron disease].
Larrode-Pellicer P; Alberti-González O; Iñiguez-Martínez C; Santos Lasaosa S; Pérez-Lázaro C; López del Val LJ
Neurologia; 2007; 22(6):362-7. PubMed ID: 17610164
[TBL] [Abstract][Full Text] [Related]
58. Pure primary lateral sclerosis--Case reports.
Tomik B; Zur KA; Szczudlik A
Clin Neurol Neurosurg; 2008 Apr; 110(4):387-91. PubMed ID: 18262342
[TBL] [Abstract][Full Text] [Related]
59. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis.
Carvalho MD; Swash M
Amyotroph Lateral Scler; 2009 Feb; 10(1):53-7. PubMed ID: 18985466
[TBL] [Abstract][Full Text] [Related]
60. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
Gordon PH; Cheung YK
Neurology; 2006 Oct; 67(7):1314-5; author reply 1314-5. PubMed ID: 17030785
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
